Hoimes, C. J., Adra, N., Fleming, M. T., Kaimakliotis, H. Z., Picus, J., Smith, Z. L., … Kelly, W. K. (2020). Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).

Hoimes, Christopher J., Nabil Adra, Mark T. Fleming, Hristos Z. Kaimakliotis, Joel Picus, Zachary L. Smith, Radhika Walling, et al. “Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.

Hoimes CJ, Adra N, Fleming MT, Kaimakliotis HZ, Picus J, Smith ZL, et al. Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.

Hoimes, Christopher J., et al. “Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.

Hoimes CJ, Adra N, Fleming MT, Kaimakliotis HZ, Picus J, Smith ZL, Walling R, Trabulsi EJ, Hoffman-Censits JH, Koch MO, Cary C, Abouassaly R, Eitman C, Fu P, Goolamier G, Calaway AC, Ponsky LE, Kelly WK. Phase Ib/II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC): Final results from the cisplatin (C)- eligible cohort of HCRN GU14-188. JOURNAL OF CLINICAL ONCOLOGY. 2020.